Bayer AG ADR (BAYRY) Social Stream
BAYER AKTIENGESELLSCHAFT (BAYRY) Price Targets From Analysts
Use the tables below to see what analysts covering BAYER AKTIENGESELLSCHAFT think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
BAYRY's average price target has moved up $4.8 over the prior 112 days.
Over the past 32 weeks, BAYRY's average upside potential has been 23.91%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
BAYRY Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
BAYRY's average broker recommendation rating improved by 1 over the prior 30 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BAYRY as an investment opportunity.
- In terms of how BAYER AKTIENGESELLSCHAFT fares relative to all US stocks, note that its variance in analysts' estimates is lower than 69.78% of that group.
- BAYRY has a greater number of analysts covering the stock than 13.74% of stocks in the large market cap category.
- BAYER AKTIENGESELLSCHAFT's average analyst price target is higher than 54.83% of stocks in the large market cap category.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, BAYER AKTIENGESELLSCHAFT's upside potential (average analyst target price relative to current price) is greater than 95.31% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BAYER AKTIENGESELLSCHAFT are ALNY, ALKS, and ABCL.
Make investment decisions regarding BAYRY using the data that counts. Try POWR Ratings for free.